Literature DB >> 18045866

Memo is homologous to nonheme iron dioxygenases and binds an ErbB2-derived phosphopeptide in its vestigial active site.

Chen Qiu1, Susanne Lienhard, Nancy E Hynes, Ali Badache, Daniel J Leahy.   

Abstract

Memo (mediator of ErbB2-driven cell motility) is a 297-amino-acid protein recently shown to co-precipitate with the C terminus of ErbB2 and be required for ErbB2-driven cell motility. Memo is not homologous to any known signaling proteins, and how it mediates ErbB2 signals is not known. To provide a molecular basis for understanding Memo function, we have determined and report here the 2.1A crystal structure of human Memo and show it be homologous to class III nonheme iron-dependent dioxygenases, a structural class that now includes a zinc-binding protein of unknown function. No metal binding or enzymatic activity can be detected for Memo, but Memo does bind directly to a specific ErbB2-derived phosphopeptide encompassing Tyr-1227 using its vestigial enzymatic active site. Memo thus represents a new class of phosphotyrosine-binding protein.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18045866     DOI: 10.1074/jbc.M703523200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Oxidative opening of the aromatic ring: Tracing the natural history of a large superfamily of dioxygenase domains and their relatives.

Authors:  A Maxwell Burroughs; Margaret E Glasner; Kevin P Barry; Erika A Taylor; L Aravind
Journal:  J Biol Chem       Date:  2019-05-15       Impact factor: 5.157

2.  Mediator of ERBB2-driven cell motility (MEMO) promotes extranuclear estrogen receptor signaling involving the growth factor receptors IGF1R and ERBB2.

Authors:  Kai Jiang; Zhihong Yang; Long Cheng; Shibin Wang; Kang Ning; Lei Zhou; Jing Lin; Hui Zhong; Lisheng Wang; Yang Li; Junjian Huang; Hao Zhang; Qinong Ye
Journal:  J Biol Chem       Date:  2013-07-16       Impact factor: 5.157

3.  Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.

Authors:  Bethany N Hannafon; Paola Sebastiani; Antonio de las Morenas; Jining Lu; Carol L Rosenberg
Journal:  Breast Cancer Res       Date:  2011-03-04       Impact factor: 6.466

4.  MHO1, an evolutionarily conserved gene, is synthetic lethal with PLC1; Mho1p has a role in invasive growth.

Authors:  Ivan D Schlatter; Maria Meira; Vanessa Ueberschlag; Dominic Hoepfner; Rao Movva; Nancy E Hynes
Journal:  PLoS One       Date:  2012-03-07       Impact factor: 3.240

5.  Memo has a novel role in S1P signaling and is [corrected] crucial for vascular development.

Authors:  Shunya Kondo; Alessia Bottos; Jeremy C Allegood; Regis Masson; Francisca G Maurer; Christel Genoud; Patrick Kaeser; Andrea Huwiler; Masato Murakami; Sarah Spiegel; Nancy E Hynes
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240

Review 6.  Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.

Authors:  Louise Pinet; Nadine Assrir; Carine van Heijenoort
Journal:  Biomolecules       Date:  2021-11-14

7.  Redox-Dependent Bone Alkaline Phosphatase Dysfunction Drives Part of the Complex Bone Phenotype in Mice Deficient for Memo1.

Authors:  Matthias B Moor; Suresh K Ramakrishnan; Finola Legrand; Silvia Dolder; Mark Siegrist; Fanny Durussel; Gabriel Centeno; Dmitri Firsov; Nancy E Hynes; Willy Hofstetter; Olivier Bonny
Journal:  JBMR Plus       Date:  2018-01-17

8.  Renal Memo1 Differentially Regulates the Expression of Vitamin D-Dependent Distal Renal Tubular Calcium Transporters.

Authors:  Matthias B Moor; Barbara Haenzi; Finola Legrand; Robert Koesters; Nancy E Hynes; Olivier Bonny
Journal:  Front Physiol       Date:  2018-07-09       Impact factor: 4.566

Review 9.  Finding MEMO-Emerging Evidence for MEMO1's Function in Development and Disease.

Authors:  Michaela D Schotanus; Eric Van Otterloo
Journal:  Genes (Basel)       Date:  2020-11-06       Impact factor: 4.096

10.  miR-219a-1 inhibits colon cancer cells proliferation and invasion by targeting MEMO1.

Authors:  Keqing Xu; Jie Shi; Dongping Mo; Yanhua Yang; Qiang Fu; Ying Luo
Journal:  Cancer Biol Ther       Date:  2020-11-20       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.